SEC Comment Letter for NuCana plc (NCNA) (CIK 0001709626) (NCNA) — Oct 10, 2018
NuCana plc (NCNA) (CIK 0001709626)
Date: Oct. 10, 2018 · CIK: 0001709626 · Accession: 0000000000-18-031737
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227624
Letter
October 9, 2018 Hugh S. Griffith Chief Executive Officer NuCana plc 3 Lochside Way Edinburgh, EH12 9DT United Kingdom Re:NuCana plc Registration Statement on Form F-3 Filed October 1, 2018 File No. 333-227624 Dear Mr. Griffith: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: John T. Rudy, Esq.
Show Raw Text
October 9, 2018
Hugh S. Griffith
Chief Executive Officer
NuCana plc
3 Lochside Way
Edinburgh, EH12 9DT
United Kingdom
Re:NuCana plc
Registration Statement on Form F-3
Filed October 1, 2018
File No. 333-227624
Dear Mr. Griffith:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: John T. Rudy, Esq.